Arix Bioscience plc: Harpoon Announces Proposed Public Offering in the United States |
December 28, 2018 | December 2018 Bond Updates |
Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company
supporting medical innovation, today notes that its portfolio company Harpoon Therapeutics,
Inc. ("Harpoon") has filed a registration statement on Form S-1 with the U.S. Securities
and Exchange... |
View more at: https://www.prnewswire.com:443/news-releases/arix-bioscience-plc-harpoon-announces-proposed-public-offering-in-the-united-states-894957491.html |
Related News |
|